BioCentury
ARTICLE | Company News

Calydon, Cell Genesys deal

August 6, 2001 7:00 AM UTC

CEGE will acquire Calydon for about 935,000 CEGE shares valued at $17.4 million based on a 30 trading day closing price average ending July 31. CEGE, which also will assume $2.6 million in Calydon lia...